Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
The backstory: CVS Caremark, the nations largest pharmacy benefit manager, stopped covering Zepbound on July 1, 2025, after reaching a deal with Novo Nordisk, the maker of rival GLP-1 drug Wegovy
(Victoza contains the same active ingredient as Saxenda but is used for Type 2 diabetes and cardiovascular risk reduction.) Other Saxenda alternatives include Ozempic (semaglutide), Mounjaro (tirzepatide), metformin, Qsymia (phentermine/topiramate), and Contrave (naltrexone/bupropion)
pylori -induced gastric erosive lesions in the animal model (49)
GLP-1R side chains within 3 of Ex4-d-Ala are shown as cyan sticks
US$ 23.35
US$ 27.92
US$ 20.13
US$ 23.83
US$ 25.48
US$ 22.02
US$ 21.76
US$ 27.72
US$ 29.06
US$ 21.06
